Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases

The cloning of the first nuclear receptor cDNA encoding the human glucocorticoid receptor was described in 1985 by the team of Evans [1]. Over the next 25 years a dramatic growth of knowledge on nuclear receptors followed this discovery [2]. The knowledge on nuclear receptors has delivered novel...

Mô tả đầy đủ

Đã lưu trong:
Chi tiết về thư mục
Những tác giả chính: Junien, J.L, Staels, B
Định dạng: Sách
Ngôn ngữ:English
Được phát hành: IOS Press 2013
Những chủ đề:
Truy cập trực tuyến:http://scholar.dlu.edu.vn/thuvienso/handle/DLU123456789/35229
Các nhãn: Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
Thư viện lưu trữ: Thư viện Trường Đại học Đà Lạt
id oai:scholar.dlu.edu.vn:DLU123456789-35229
record_format dspace
spelling oai:scholar.dlu.edu.vn:DLU123456789-352292014-01-20T00:05:45Z Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases Junien, J.L Staels, B System Targets The cloning of the first nuclear receptor cDNA encoding the human glucocorticoid receptor was described in 1985 by the team of Evans [1]. Over the next 25 years a dramatic growth of knowledge on nuclear receptors followed this discovery [2]. The knowledge on nuclear receptors has delivered novel therapies for lipid control and hormone replacement, and for management of cancers and diabetes, and millions of humans were subjected to therapies with nuclear receptor modulators over last decades 2013-08-27T09:24:10Z 2013-08-27T09:24:10Z 2008 Book 978-1-58603-857-1 http://scholar.dlu.edu.vn/thuvienso/handle/DLU123456789/35229 en application/pdf IOS Press
institution Thư viện Trường Đại học Đà Lạt
collection Thư viện số
language English
topic System
Targets
spellingShingle System
Targets
Junien, J.L
Staels, B
Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases
description The cloning of the first nuclear receptor cDNA encoding the human glucocorticoid receptor was described in 1985 by the team of Evans [1]. Over the next 25 years a dramatic growth of knowledge on nuclear receptors followed this discovery [2]. The knowledge on nuclear receptors has delivered novel therapies for lipid control and hormone replacement, and for management of cancers and diabetes, and millions of humans were subjected to therapies with nuclear receptor modulators over last decades
format Book
author Junien, J.L
Staels, B
author_facet Junien, J.L
Staels, B
author_sort Junien, J.L
title Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases
title_short Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases
title_full Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases
title_fullStr Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases
title_full_unstemmed Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases
title_sort nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases
publisher IOS Press
publishDate 2013
url http://scholar.dlu.edu.vn/thuvienso/handle/DLU123456789/35229
_version_ 1757663804152348672